It is one of the largest custom manufacturing companies in the world which provides flexibility and scalability of operations.
Pharma Solutions is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services required to bring a drug to the market place faster. We offer pharmaceutical development and manufacturing solutions through collaborative partnerships and work with our customers throughout the drug life cycle.
Our development centres and manufacturing sites have accreditations from regulatory bodies in US, Europe and Japan. With a pool of 450 scientists, including 100 PhDs, across the globe, we are committed to research and development programs. We offer specialized services such as Antibody Drug Conjugation and are well versed with technologies such as Bio-catalysis.
This division features among the top 10 contract drug manufacturers in the world as per the UN Conference on Trade and Development report. In March 2014 we won two awards for "Quality" and "Reliability" in the CRO/CMO by Life Science Leaders.
Our Critical Care division focuses on innovative solutions that create value for both patients and care providers.
Critical Care, a unit of Piramal Healthcare is a global leader in the field of anesthesia. "Save lives with innovative critical care solutions" is much more than a purpose statement for us. Our consistent efforts and commitment towards the critical care fraternity has helped us expand and gain prominence in markets across the globe.
We are the world's third largest producers of Inhaled Anesthetics and are widely present across Europe and USA. Our portfolio includes Inhalation Anesthetics such as Halothane, Isoflurane and Sevoflurane as well as critical care products like Propofol and plasma volume expanders like Polygeline. Our commitment to quality resonates in global regulatory approvals that are accredited to our manufacturing plants. Their strategic location enables us to supply products throughout the world with great flexibility, helping us adhere to our commitment of uninterrupted delivery.
The Critical Care division came into being in 2002 with the acquisition of ICI India Ltd. followed by a string of other acquisitions involving long-established manufacturers of well-known, trusted products. Our strength lies in our culturally diversified team of 350 members from 20 nationalities, based out of 15 countries world over, with major operations in the USA.
Piramal Enterprises Ltd. Healthcare Vertical has a Consumer Product division which is one of the fastest growing players in the Domestic Consumer Healthcare Market.
The Indian Self-care Market is sized at 100 Billion and has a large number of players operating in the Healthcare and Wellness segment.
Piramal Enterprises Ltd. entered the OTC market with the acquisition of Saridon from Roche and Lacto Calamine from Duphar in the early 1990s. In 2007 - Piramal Enterprises Ltd. decided to be independent and established its own Consumer Products Division.
Our OTC range straddles the pharmaceutical as well as the personal care space with most-trusted brands in diverse product categories like Vitamins & Nutrition, Analgesics, Dermatological & Antacids The business boasts of 10 major brands with 30 SKUs
Providing innovative diagnostic imaging agents, the imaging division aims to serve patients better, using world-class technology through our subsidiary.
A product portfolio of innovative molecular imaging probes, that address major clinical needs in oncology (inter alia prostate cancer), neurodegenerative and cardiovascular diseases, is a testimony to our intensive research and development.
Our lead compound is [18F] florbetaben – an 18F-labeled tracer used in positron emission tomography (PET). Florbetaben specifically binds to beta-amyloid deposits in the brain, a key pathological hallmark in Alzheimer's disease. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have recently approved Neuraceq™ (Florbetaben F18 injection) for PET Imaging of Beta-Amyloid Neuritic Plaques in the Brain.
PhytoMedicines™ is engaged in developing and marketing standardized healthcare solutions derived from natural sources such as plants.
We follow stringent norms for standardization, validation and product development ensuring world class quality and consistent performance; thus applying the rigours of modern science to the goodness of natural medicine. The intrinsic benefits of herbal product include greater efficacy, little or no side effects and availability at affordable prices. We plan to leverage India's biodiversity and vast pool of knowledge in traditional medicinal systems such as Ayurveda as a source for new medications. Our varied range of products have been developed to help manage lifestyle ailments such as Diabetes, Arthritis, Obesity, Constipation, Liver damage, Anxiety, Sexual dysfunction, Cough and Cold, etc.